share_log

China National Chemical Engineering's (SHSE:601117) Three-year Earnings Growth Trails the Respectable Shareholder Returns

China National Chemical Engineering's (SHSE:601117) Three-year Earnings Growth Trails the Respectable Shareholder Returns

中國化學工程(上海證券交易所代碼:601117)的三年收益增長落後於可觀的股東回報
Simply Wall St ·  2023/10/09 18:03

By buying an index fund, investors can approximate the average market return. But if you pick the right individual stocks, you could make more than that. For example, China National Chemical Engineering Co., Ltd (SHSE:601117) shareholders have seen the share price rise 45% over three years, well in excess of the market decline (12%, not including dividends). On the other hand, the returns haven't been quite so good recently, with shareholders up just 6.6% , including dividends .

通過購買指數基金,投資者可以接近平均市場回報。但如果你選擇了正確的個股,你可以賺得更多。例如,中國國家化工股份有限公司(上海證券交易所:601117)股東看到股價在三年內上漲了45%,遠遠超過了市場跌幅(12%,不包括股息)。另一方面,最近的回報率並不是很好,包括股息在內,股東的回報率僅為6.6%。

The past week has proven to be lucrative for China National Chemical Engineering investors, so let's see if fundamentals drove the company's three-year performance.

事實證明,過去一週對中國化學工程的投資者來說是有利可圖的,所以讓我們看看基本面因素是否推動了該公司三年的業績。

View our latest analysis for China National Chemical Engineering

看我們對中國化工的最新分析

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

不可否認,市場有時是有效的,但價格並不總是反映潛在的商業表現。一種不完美但簡單的方法來考慮市場對一家公司的看法是如何改變的,那就是將每股收益(EPS)的變化與股價走勢進行比較。

During three years of share price growth, China National Chemical Engineering achieved compound earnings per share growth of 17% per year. This EPS growth is higher than the 13% average annual increase in the share price. Therefore, it seems the market has moderated its expectations for growth, somewhat. We'd venture the lowish P/E ratio of 8.60 also reflects the negative sentiment around the stock.

在三年的股價增長中,中國化工實現了每股收益年均17%的復合增長。這一EPS增幅高於該公司股價13%的年均增幅。因此,市場似乎在一定程度上降低了對增長的預期。我們敢打賭,8.60的低本益比也反映了圍繞該股的負面情緒。

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

該公司的每股收益(在一段時間內)如下圖所示(點擊查看具體數位)。

earnings-per-share-growth
SHSE:601117 Earnings Per Share Growth October 9th 2023
上交所:2023年10月9日每股收益增長601117

It's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. This free interactive report on China National Chemical Engineering's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

可能值得注意的是,首席執行官的薪酬低於類似規模公司的中位數。但是,儘管CEO的薪酬總是值得檢查的,但真正重要的問題是,公司能否在未來實現收益增長。這免費如果你想進一步調查中國的股票,那麼關於國化的收益、收入和現金流的互動報告是一個很好的起點。

What About Dividends?

那股息呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for China National Chemical Engineering the TSR over the last 3 years was 56%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the total shareholder return.

在考察投資回報時,重要的是要考慮到股東總回報(TSR)和股價回報。雖然股價回報只反映股價的變動,但TSR包括股息的價值(假設股息再投資),以及任何折價集資或分拆所帶來的利益。因此,對於支付豐厚股息的公司來說,TSR往往比股價回報高得多。我們注意到,中國化工過去3年的TSR為56%,好於上述股價回報。該公司支付的股息因此提振了總計股東回報。

A Different Perspective

不同的視角

We're pleased to report that China National Chemical Engineering shareholders have received a total shareholder return of 6.6% over one year. And that does include the dividend. However, the TSR over five years, coming in at 9% per year, is even more impressive. Potential buyers might understandably feel they've missed the opportunity, but it's always possible business is still firing on all cylinders. It's always interesting to track share price performance over the longer term. But to understand China National Chemical Engineering better, we need to consider many other factors. To that end, you should be aware of the 1 warning sign we've spotted with China National Chemical Engineering .

我們很高興地報告,中國化工的股東在一年內獲得了6.6%的總股東回報。這確實包括了股息。然而,五年來的TSR,以每年9%的速度增長,更令人印象深刻。潛在買家可能會覺得他們錯過了預期的機會,這是可以理解的,但業務仍有可能仍然全速運轉。跟蹤股價的長期表現總是很有趣的。但要更好地理解中國國化,還需要考慮很多其他因素。為此,您應該意識到1個個警告標誌我們已經與中國國家化工公司進行了連線。

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一樣,你會的想懷念這一切嗎?免費內部人士正在收購的成長型公司名單.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論